| ActiBiso™ C8G | Bisor Corporation |
|
ActiBiso™ C8G is good for skin moisturizing and collagen synthesis. It can regulate alkaline acidity, balance the skin environment, prevent excessive keratinization, and inhibit harmful microorganisms. It is used for preparing anti-acne, anti-aging, and a...voir plus
ActiBiso™ C8G is good for skin moisturizing and collagen synthesis. It can regulate alkaline acidity, balance the skin environment, prevent excessive keratinization, and inhibit harmful microorganisms. It is used for preparing anti-acne, anti-aging, and advanced skin care cream and emulsion products. voir moins
Compliance Highlights Unavailable
|
Request Sample |
| ActiBiso™ GHS | Bisor Corporation |
|
ActiBiso™ GHS is composed of glutamic acid, cysteine, and glycine. It contains sulfhydryl group. It has the function of anti-oxidation and integrated detoxification, therefore it can transform harmful poisons into harmless substances and excrete them out ...voir plus
ActiBiso™ GHS is composed of glutamic acid, cysteine, and glycine. It contains sulfhydryl group. It has the function of anti-oxidation and integrated detoxification, therefore it can transform harmful poisons into harmless substances and excrete them out of the body. Glutathione also helps maintain normal immune system function. There is the use of the whitening needle, which can whiten the skin through the metabolism of toxins. voir moins
Compliance Highlights Available
|
Request Sample |
| ActiBiso™ UP | Bisor Corporation |
|
ActiBiso™ UP is a relatively new whitening ingredient that controls the binding of α-MSH(melanin cytosine hormone) to melanin production factor and blocks the process of melanin formation. According to the study, this component can block α-MSH at 0.001%, ...voir plus
ActiBiso™ UP is a relatively new whitening ingredient that controls the binding of α-MSH(melanin cytosine hormone) to melanin production factor and blocks the process of melanin formation. According to the study, this component can block α-MSH at 0.001%, if used at 1%. The results showed that melanin production was inhibited comprehensively from multiple links, and the effect was more obvious and lasting. voir moins
Compliance Highlights Available
|
Request Sample |
| Traxmic™ | Bisor Corporation |
|
Traxmic™ is a synthetic derivative of the amino acid lysine with antifibrinolytic activity. With a strong affinity for the five lysine-binding sites of plasminogen, Traxmic™ competitively inhibits the activation of plasminogen to plasmin, resulting in inh...voir plus
Traxmic™ is a synthetic derivative of the amino acid lysine with antifibrinolytic activity. With a strong affinity for the five lysine-binding sites of plasminogen, Traxmic™ competitively inhibits the activation of plasminogen to plasmin, resulting in inhibition of fibrinolysis; at higher concentrations, this agent noncompetitively inhibits plasmin. This agent has a longer half-life, is approximately ten times more potent, and is less toxic than aminocaproic acid, which possesses similar mechanisms of action. voir moins
Compliance Highlights Available
|
Request Sample |
